rolipram and rs 25344
rolipram has been researched along with rs 25344 in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bjornsson, JM; Burgin, AB; Gurney, ME; Hagen, T; Hrafnsdottir, S; Kiselyov, AS; Magnusson, OT; Singh, J; Staker, BL; Stewart, LJ; Thorsteinsdottir, M; Witte, P | 1 |
Abraham, A; Adams, DR; Allcock, RW; Anthony, D; Baillie, GS; Bogum, J; Christian, F; Day, JP; Houslay, DM; Houslay, MD; Huston, E; Jiang, Z; Klussmann, E; Lindsay, B; Martin, EK; Rae, RL; Riddell, T; Rosair, GM; Sookup, S | 1 |
de Esch, IJ; de Graaf, C; Jansen, C; Kanev, GK; Kooistra, AJ; Leurs, R | 1 |
Kim, E; Kim, JH; Kim, SH; Nam, G; Rhee, CK; Shin, JH; Yoon, CM | 1 |
Other Studies
4 other study(ies) available for rolipram and rs 25344
Article | Year |
---|---|
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety.
Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Behavior, Animal; Benzhydryl Compounds; Biological Assay; Catalytic Domain; Cell Line; Cognition; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Drug Design; Humans; Kinetics; Mice; Models, Molecular; Molecular Sequence Data; Phenylurea Compounds; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Protein Structure, Tertiary; Structure-Activity Relationship; Vomiting | 2010 |
Elucidation of a structural basis for the inhibitor-driven, p62 (SQSTM1)-dependent intracellular redistribution of cAMP phosphodiesterase-4A4 (PDE4A4).
Topics: Adaptor Proteins, Signal Transducing; Animals; Catalytic Domain; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Isoenzymes; Models, Molecular; Phosphodiesterase 4 Inhibitors; Pyridines; Rolipram; Sequestosome-1 Protein; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Xanthines | 2011 |
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.
Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship | 2016 |
Syntheses and evaluation of pyrido[2,3-dlpyrimidine-2,4-diones as PDE 4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Biological Assay; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; Molecular Structure; Phosphodiesterase Inhibitors; Pyrimidines; Quinazolines; Rats; Rolipram | 2001 |